CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- Open-market buys, last 90 days
- $99,331
- in 1 filing
- Open-market sales, last 90 days
- $378,930
- in 4 filings, $379K under 10b5-1 plans
Net −$279,599. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 92 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Daly Richard J Director | Purchase | +1,200 | $3.53 | $4K | 1,200 |
| 2026-11-10 | Daly Richard J Director | Purchase | +26,825 | $3.55 | $95K | 28,025 |
| 2026-11-10 | Davis Matthew W. Chief Development Officer | Shares withheld for taxes | −5,303 | $3.52 | $19K | 94,697 |
| 2026-11-06 | Daly Richard J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +57,000 | 57,000 | ||
| 2026-10-21 | Cochran John Director | Other acquisition | +62,229 | 161,715 | ||
| 2026-10-15 | Barber Daniel President and CEO | Sale 10b5-1 | −25,000 | $4.22 | $106K | 627,317 |
| 2026-09-15 | Barber Daniel President and CEO | Sale 10b5-1 | −25,000 | $4.82 | $120K | 652,317 |
| 2026-09-09 | Korczynski Sherry Chief Commercial Officer | Option exercise 10b5-1 | +8,750 | $2.65 | $23K | 244,439 |
| 2026-09-09 | Korczynski Sherry Chief Commercial Officer | Sale 10b5-1 | −8,750 | $5.22 | $46K | 235,689 |
| 2026-09-09 | Korczynski Sherry Chief Commercial Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −8,750 | 26,250 | ||
| 2026-09-09 | Boyd Peter E. Chief People Officer | Option exercise | +2,293 | $0.96 | $2K | 284,024 |
| 2026-09-09 | Boyd Peter E. Chief People Officer | Option exercise · Warrant (Right to Buy) | −2,293 | 0 | ||
| 2026-09-08 | Barber Daniel President and CEO | Option exercise | +91,743 | $0.96 | $88K | 677,317 |
| 2026-09-08 | Barber Daniel President and CEO | Option exercise · Warrant (Right to Buy) | −91,743 | 0 | ||
| 2026-09-03 | Jung Cassie Chief Operating Officer | Option exercise | +4,587 | $0.96 | $4K | 206,833 |
| 2026-09-03 | Jung Cassie Chief Operating Officer | Option exercise · Warrant (Right to Buy) | −4,587 | 0 | ||
| 2026-08-17 | Barber Daniel President and CEO | Sale 10b5-1 | −25,000 | $4.29 | $107K | 585,574 |
| 2026-08-14 | Korczynski Sherry Chief Commercial Officer | Shares withheld for taxes | −2,714 | $4.25 | $12K | 235,689 |
| 2026-07-16 | Barber Daniel President and CEO | Sale 10b5-1 | −20,369 | $4.00 | $82K | 610,574 |
| 2026-07-15 | Barber Daniel President and CEO | Sale 10b5-1 | −4,631 | $4.03 | $19K | 630,943 |
Page 1 of 15 · 300 trades